Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Northfield, Ill.-based Medline received Vizient's Mark McKenna Overall Supplier of the Year Award during the 2017 Vizient Supplier Summit held April 3-5 in Las Vegas.
Teva Pharmaceuticals on Friday received Food and Drug Administration approval for the first generic version of Gilead Science's best-selling HIV drug Truvada, reports Regulatory Focus.
Lupin Pharmaceuticals recalled its Mibelas 24 Fe birth control tablets following confirmed reports of a packaging error.
Several devicemakers are using a new blood perfusion technology to transform the way donor organs are preserved and transferred, reports NBC News.
Bristol-Myers Squibb lost $37 billion in market value this past year due to a failed clinical trial for a new lung cancer treatment indication of its best-selling cancer drug Opdivo. Industry analysts believe the financial setback puts the drugmaker in…
The Food and Drug Administration on Thursday approved Qiagen's fourth generation tuberculosis blood test.
A new report conducted by Patient View, a patient insight organization, explores the corporate reputation of the pharmacy industry from the perspective of cancer patients.
HHS Secretary Tom Price, MD, reiterated the importance of lowering prescription drug costs during a Thursday hearing with the Senate Finance Committee, reports Bloomberg,
The congressional MedTech caucus held a briefing Thursday about technological advancements made toward curbing cardiovascular disease.
The House Energy and Commerce Committee on June 7 unanimously passed a bill to reauthorize the Food and Drug Administration's user fee program, the Washington Examiner reports.